FDA Approved: IRBESARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's supplemental application for IRBESARTAN, enabling the generic ARB formulation to be marketed in the United States…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)